Logistics and comparisons will bring growth down for Ambu, analyst says
Senior analyst at Sydbank Søren Løntoft Hansen has subdued expectations for the first quarter of medtech company Ambu.
by marketwire, translated by daniel pedersen
The first quarter for the skewed 2021/2022 financial year will be marked by a difficult basis of comparison and continued logistical challenges, both of which will put a damper on the report, says Søren Løntoft Hansen, senior equity analyst at Danish bank Sydbank, prior to the report’s release on February 8.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu launches two new endoscope carts
For subscribers
Ambu's Ascope Gastro and Abox 2 approved by FDA
For subscribers
.jpg&w=384&q=75)
